Stock Ratings | Canaccord Genuity lowered its price target for Ocugen (OCGN) to $11, indicating a potential upside of 679.1%; Tigress Financial raised its price target for Nvidia (NVDA) to $425
NVIDIA Corporation NVDA | 0.00 | |
DeFi Development DFDV | 0.00 | |
Apogee Therapeutics, Inc. APGE | 0.00 | |
Century Therapeutics, Inc. IPSC | 0.00 | |
OCUGEN INC OCGN | 0.00 |
The ratings of major US investment banks are used to track the latest valuations and target prices on Wall Street daily, and to explore potential equity investment opportunities.
Risk warning:
Investing in small-cap stocks can be risky. Be prepared for potential challenges related to liquidity, high volatility, limited information, and financial instability. Always diversify your investments.
Today's key assessments and concerns
Tigress Financial: Maintaining a "Strong Buy" rating on NVIDIA NVIDIA Corporation(NVDA.US) ) stock, while raising its price target from $360 to $425.
Cantor Fitzgerald: Maintaining an "overweight" rating for DeFi Development ( DeFi Development(DFDV.US) ), while raising the price target from $6 to $7.
Wedbush: Maintaining Apogee Apogee Therapeutics, Inc.(APGE.US) rating at "Outperform Market", while raising price target from $120 to $135.
Mizuho: Initial rating for Century Therapeutics ( Century Therapeutics, Inc.(IPSC.US) ) at "Outperform Market", with a price target of $8.
Canaccord Genuity: Maintaining a "buy" rating on Ocugen ( OCUGEN INC(OCGN.US) ) stock, while lowering the price target from $12 to $11.
| The symbol | Classification | Target price | Current price | Percentage of potential increase/decrease | (Classification) Agency |
| NVIDIA Corporation(NVDA.US) | to lift | $425.0 | $212.6 | 99.91% | Tigress Financial |
| DeFi Development(DFDV.US) | to lift | $7.0 | $3.9 | 79.49% | Cantor Fitzgerald |
| Apogee Therapeutics, Inc.(APGE.US) | to lift | $135.0 | $77.75 | 73.63% | Wedbush |
| Antero Resources Corporation(AR.US) | to lift | $54.0 | $35.11 | 53.8% | Mizuho |
| Devon Energy Corporation(DVN.US) | to lift | $68.0 | $44.27 | 53.6% | Mizuho |
| Century Therapeutics, Inc.(IPSC.US) | Initial classification | $8.0 | $2.305 | 247.07% | Mizuho |
| OCUGEN INC(OCGN.US) | cut | $11.0 | $1.38 | 697.1% | Canaccord Genuity |
| Corbus Pharmaceuticals Holdings Inc(CRBP.US) | cut | $30.0 | $7.82 | 283.63% | Wedbush |
| Verra Mobility Corp. Class A(VRRM.US) | cut | $9.0 | $3.85 | 133.77% | Deutsche Bank |
| Verra Mobility Corp. Class A(VRRM.US) | cut | $8.0 | $3.85 | 107.79% | Baird |
comments:
Target price unit and current price: US Dollar;
Current price: As of the latest closing price of US stocks;
Potential percentage increase/potential decrease = (Agency target price - current price) / current price 100% (Current price = Last closing price up to the time of the count)
Lifting
Wedbush: Maintaining its "Outperform Market" rating for CrowdStrike Holdings CrowdStrike(CRWD.US) , while raising its price target from $550 to $700.
B. Riley Securities: Maintaining a "Buy" rating on IREN Limited ( IREN Limited(IREN.US) ), with a price target raised from $83 to $88.
Barclays: Maintaining Micron Technology's Micron Technology, Inc.(MU.US) ) rating at "overweight", while raising the price target from $675 to $1175.
Mizuho: Maintaining an "outperform" rating for Occidental Occidental Petroleum Corporation(OXY.US) ) stock, while raising the price target from $72 to $75.
Wedbush: Maintaining Palo Alto Networks’ Palo Alto Networks, Inc.(PANW.US) ) rating at “Outperform Market”, while raising the price target from $225 to $300.
Barclays: Upgraded SanDisk ( Sandisk Corporation(SNDK.US) ) stock rating to "overweight", raising the price target from $1,200 to $2,300.
Bernstein: Maintaining its "outperform" rating for UnitedHealth ( UnitedHealth Group Incorporated(UNH.US) ), while raising its price target from $444 to $492.
Barclays: Maintaining Western Digital's ( Western Digital Corporation(WDC.US) ) rating at "overweight", while raising the price target from $450 to $620.
First Coverage
DA Davidson: Initial rating for Cellebrite ( Cellebrite(CLBT.US) ) stock at "Buy", with a target price of $20.
Evercore ISI Group: Initial rating for DAVE ( Dave, Inc. Class A(DAVE.US) ) stock at "Market Match", with a target price of $260.
Jefferies: Initial rating for Fervo Energy ( Fervo Energy Company Class A(FRVO.US) ) stock at "Hold", with a price target of $42.
Seaport Global: Initial rating on GE Aerospace ( GE Aerospace(GE.US) ) stock at "buy", with a target price of $375.
reduction
Scotiabank: Maintaining America Movil SAB ( America Movil SAB de CV Sponsored ADR Class B(AMX.US) ) rating at "In-Sector Match", while lowering the price target from $21.8 to $20.8.
JP Morgan: Maintaining AutoZone's ( AutoZone, Inc.(AZO.US) ) rating at "overweight," while lowering the price target from $4,300 to $3,850.
Truist Securities: Maintaining a "buy" rating on Dollar Tree ( Dollar Tree, Inc.(DLTR.US) ), while lowering the price target from $142 to $107.
Cantor Fitzgerald: Maintaining the Zscaler rating ( Zscaler, Inc.(ZS.US) ) at "Overweight", while lowering the target price from $300 to $225.
Editor's Note: This content was created by Saham's AI-powered SaaS tool and reviewed by our editorial team.
Risk Warning: Investing involves risk. Securities may rise, fall, or become worthless. Investing does not guarantee profits and may result in losses. Past performance is not necessarily indicative of future results. Before making any investment decision, investors should assess their financial situation, investment objectives, experience, risk tolerance, and understand the nature of the investment products and their associated risks. For more details on the nature and risks of each investment product, please read the relevant offering documents carefully. If you have any questions, it is advisable to seek independent professional advice.
